Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
about
Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@ast
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@en
type
label
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@ast
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@en
prefLabel
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@ast
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@en
P2093
P2860
P356
P1433
P1476
Does Reduction of Number of In ...... rogenic Detrusor Overactivity?
@en
P2093
Amélie Huynh Le Maux
Bernadette Pignol
Delphine Behr-Roussel
François Giuliano
Jacques Bernabé
Jean-Luc Blachon
Philippe Picaut
Pierre Denys
Pierre-Etienne Chabrier
Sandrine Compagnie
P2860
P304
P356
10.3390/TOXINS7124896
P577
2015-12-17T00:00:00Z